Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
第一作者:
B,Sredni
第一单位:
Cancer, AIDS and Immunology Research Institute, Marilyn Finkler Cancer Research Center, Bar Ilan University, Ramat Gan, Israel.
作者:
医学主题词
佐剂, 免疫(Adjuvants, Immunologic);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);秃发(Alopecia);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓(Bone Marrow);卡铂(Carboplatin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);集落刺激因子类(Colony-Stimulating Factors);乙烯类(Ethylenes);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);白细胞介素1(Interleukin-1);白细胞介素6(Interleukin-6);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);中性粒细胞减少(Neutropenia);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);血小板减少(Thrombocytopenia)
DOI
10.1200/JCO.1995.13.9.2342
PMID
7666093
发布时间
2020-03-17
- 浏览10
Journal of clinical oncology
2342-53页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



